Insulin Resistance Linked to Liver Disease Progression in HIV/HCV Coinfected Patients

Insulin resistance is common among HIV positive people with hepatitis C virus (HCV) coinfection and is strongly associated with progression to liver fibrosis over time, Canadian researchers reported in the June 27, 2012, advance online edition of AIDS.

Read more:

Liver Fibrosis Tests Predict Mortality in HIV/HCV Coinfected Women

More advanced liver fibrosis, as diagnosed by 2 non-invasive biomarker tests, is associated with a higher risk of death for HIV positive women coinfected with hepatitis C virus (HCV), according to a report in the March 13, 2012, issue of AIDS.

Read more:

HIV/HCV Coinfected People Have Higher Risk of Hip Fractures

HIV positive people who also have hepatitis C virus (HCV) are more prone to hip fractures than people with HIV alone, HCV alone, or neither virus, according to research published in the May 22, 2012, advance online edition of Hepatology.

Read more:

CROI 2012: ART Liver Toxicity is Lower with Modern Regimens, but Still a Risk for HIV/HCV Coinfected

Liver toxicity related to antiretroviral therapy (ART) has become less common in recent years thanks to development of better tolerated drugs and improved understanding of how to use them. But HIV positive people coinfected with hepatitis C remain at higher risk, researchers reported at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this month in Seattle.

Read more:

Hepatitis B Linked to More HIV+ Deaths than Hepatitis C, Risk High for People with AIDS

HIV positive men who are coinfected with hepatitis B virus (HBV) are more likely to die than those with hepatitis C virus (HCV) coinfection, according to research published in the April 20, 2012, advance online edition of Clinical Infectious Diseases. A related study, however, found that liver-related mortality was quite high for HIV/HCV coinfected people with a diagnosis of AIDS.

Read more:

New Guidelines: Antiretroviral Therapy and Optimized Care for People with HIV

The U.S. Department of Health and Human Services this week released updated Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. DHHS panel member Paul Dalton provides a summary of the changes.

Earlier this month the International Association of Physicians in AIDS Care (IAPAC) released guidelines for improving entry into and retention in care for people with HIV, as well as optimizing adherence to antiretroviral therapy.

Read more:

Ribavirin Helps Early Hepatitis C Treatment in People with HIV

Adding ribavirin to pegylated interferon increases the likelihood of a cure for early hepatitis C virus (HCV) infection in people with HIV, according to study findings published in the May 2, 2012, advance online edition of AIDS.

Read more:

CROI 2012: HIV Treatment May Reduce Mother-to-Child Hepatitis C Transmission

Effective antiretroviral therapy (ART) for HIV and maintaining a high CD4 T-cell count may decrease the risk of hepatitis C virus (HCV) transmission from HIV/HCV coinfected mothers to their babies, according to study findings presented at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) this month in Seattle.

Read more: